Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the ...

Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of ...

The City of Somerville, Mass., also helped catalyze TransMedics’ move with a creative funding package, Tax Increment Financing (“TIF”), providing up to $18M in tax relief over ten years while creating ...

Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Traditional biomanufacturing is based on microbial or mammalian cell culture, plants can be grown in bioreactors and hold ...

Buffer Media Station Buffer Media Station Production Line 3 Production Line 3 VarmX and Rentschler Biopharma expand ...

Let’s Innovate Together!’ During my tenure as ASNC president, I will work tirelessly so we can innovate together as the ...

Now, it’s worth noting Stock Advisor’s total average return is 968 % — a market-crushing outperformance compared to 197% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

Rentschler to manufacture VarmX’s VMX-C001 for Phase 3 development and potential commercialization.

They plan to run similar trials on seven more patients over the next three years, backed by $4 million from the National ...